Germany
IP STARS, Managing IP’s accreditation title, reveals its latest rankings for patent work, including which firms are moving up
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Leaders at the IP firms, which have joined forces with backing from a PE investor, share their vision of building the number one pan-European IP practice
Stefan Müller discusses managing deadlines, the importance of reflection, and why IP is more than just a 'nice to have'
Sponsored
Sponsored
-
Sponsored by Maiwald Intellectual PropertyEva Ehlich, Angela Zumstein and James Neuhaus of Maiwald note their observations on oral proceedings before the Enlarged Board of Appeal -
Sponsored by Maiwald Intellectual PropertyEva Ehlich and Angela Zumstein of Maiwald explore why video conference technology at the EPO has caused widespread concern
-
Sponsored by Maiwald Intellectual PropertyStefanie Parchmann and Damla Simsek of Maiwald Intellectual Property consider a patent case ruling by the German Federal Court of Justice
-
Sponsored by Maiwald Intellectual PropertyMarco Stief of Maiwald takes a closer look at the key elements of the scientific research initiative that succeeded the Horizon 2020 framework programme
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer of Maiwald explores a recent decision which prevents the distribution of medicinal products by means of an automatic dispenser from a foreign mail-order pharmacy
-
Sponsored by Maiwald Intellectual PropertyIn the present case (X ZR 14/20), the German Federal Court of Justice again dealt with the question to what extent a third party who is not party to the nullity proceedings should be granted access to the files of the nullity proceedings.
